期刊文献+

右美托咪定对脓毒血症患者急性肾损伤的影响 被引量:6

下载PDF
导出
摘要 目的观察右美托咪定对脓毒血症患者急性肾损伤的影响。方法脓毒血症患者50例,性别不限,年龄50~70岁,ASA分级Ⅲ~Ⅳ级,利用随机数字表法,随机将患者分为对照组(C组)、右美托咪定组(D组)。静脉注射芬太尼、咪达唑仑、异丙酚、顺阿曲库铵行麻醉诱导,术中采用异丙酚、瑞芬太尼等静脉维持麻醉,随后间断追加去极化肌松药顺阿曲库铵。D组麻醉诱导前10 min以1μg/kg的剂量静脉输注右美托咪啶,随后以0.4μg·kg-1·h-1的静脉输液速率输注2 h。于麻醉诱导前、手术开始2 h、术后24 h(T1~T3)时观察血流动力学变化,同时采集静脉血液和尿液标本,测定血清胱抑素C(Cys-c)、肿瘤坏死因子-α(TNF-α)和尿中性粒细胞明胶酶相关脂质运载蛋白(NGAL)浓度。结果在T2、T3时D组MAP、HR明显低于C组(P〈0.05),并且D组术中瑞芬太尼和异丙酚用药量与C组比较明显减少(P〈0.05)。与C组比较,D组在T2、T3时血清Cys-c、TNF-α浓度和尿NGAL浓度明显降低(P〈0.05)。结论右美托咪定对脓毒血症患者急性肾损伤有保护作用。
作者 魏红芳
出处 《河北医药》 CAS 2016年第11期1699-1701,共3页 Hebei Medical Journal
基金 邯郸市科学技术研究与发展支撑计划项目(编号:1323108128)
  • 相关文献

参考文献18

  • 1Doi K. Role of kidney injury in sepsis. J Intensive Care ,2016,23 : 17.
  • 2Peng W, Zhang T, Wang Y. Comparison of propofol-hydromorphone and propofol-dexmedetomidine in patients with intubation after maxillofacial plastic surgery. Ther Clin Risk Manag,2016,12:373-377.
  • 3Ge YL, Li X, Gao JU, et al. Beneficial effects of intravenous dexmedeto- midine on cognitive function and cerebral injury following a carotid endar- tereetomy. Exp Ther Med ,2016,11 : 1128-1134.
  • 4Dellepiane S, Marengo M, Cantaluppi V. Detrimental cross-talk between sepsis and acute kidney injury: new pathogenic mechanisms, early bio- markers and targeted therapies. Crit Care,2016,20:61.
  • 5Honore PM, Jacobs R, Hendrickx I, et al. Prevention and treatment of sep- sis-induced acute kidney injury:an update. Ann Intensive Care,2015,5: 51.
  • 6Umbro I, Gentile G, Tinti F, et al. Recent advances in pathophysiology and biomarkers of sepsis-induced acute kidney injury. J Infeet ,2016,72: 131-42.
  • 7Dellepiane S, Marengo M, Cantaluppi V. Detrimental cross-talk between sepsis and acute kidney injury: new pathogenic meehanisms,earlybiomar- kers and targeted therapies. Crit Care,2016,20:61.
  • 8Keltanen T, Walta AM, Salonen S, et al. Renal markers cystatin C and neutrophil gelatinase-assoeiated lipocalin (NGAL) in postmortem sam- pies. Forensic Sci Med Pathol,2016,12 : 189-192.
  • 9Ebert N, Delanaye P, Shlipak M, et al. Cystatin C standardization decrea- ses assay variation and improves assessment of glomerular filtration rate. Clin Chim Acta,2016.456 : 115-121.
  • 10Uzun H, Ozmen M,Ataman R,et al. Serum systatin C level as a poten- tially goodmarker for impaired kindney function. Clin Biochem, 2005, 38:792-798.

同被引文献92

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部